Jean-Paul Clozel
Article Abstract:
Jean-Paul Clozel, the CEO of Switzerland's largest biotech firm, Actelion Pharmaceuticals, owes his success to the drug Tracleer, a treatment for pulmonary arterial hypertension. This disease affects 145,000 people in the U.S. and Europe and the product had sales exceeding $480 million in 2005 across more than 30 countries. Due to Clozel's ultimate dream of discovering new drugs, he went on to co-found Actelion.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
Fighting company spin
Article Abstract:
A few indicators that can signal whether the company uses or abuses the most important press releases such as the ones that appear at quarterly or annual earnings time are discussed. Many companies disseminate press releases most commonly online through BusinessWire or PR Newswire.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2003
User Contributions:
Comment about this article or add new information about this topic:
Biotech at the beauty counter
Article Abstract:
More and more biotech companies are making profit by entering the cosmeceutical sector due to increase in consumer demand.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Tweedie's best of breed. Otty the younger. Nick Land loses office
- Abstracts: Diversifying in biotech. Does biotech M&A benefit investors?. Biotech IPOs: handle with care
- Abstracts: Three US states launch biotech seed funds. Global biotech expansion taking cues from Bayh-Dole. Unlocking the money-making potential of RNAi
- Abstracts: Insect resistance management in GM crops: Past, present and future. Transgenic plants expressing two Bacillus thuringiensis toxins delay insect resistance evolution
- Abstracts: Materials exchange deal meager boost to India's biotech. U.S. biodefense-shocking and awful. US food aid still under GM cloud